IDL (CFDA) / Taiwan DMF (TFDA)
As of 31 December 2020
| Year | APIs | No |
|---|---|---|
| Total | 4 | |
| 2020 | Cefotaxime Sodium (Taiwan DMF), Lenalidomide α Form (Taiwan DMF) | 2 |
| Before 2015 | Ceftizoxime Na (IDL), Pitavastatin Ca (Taiwan DMF) | 2 |
Copyright 2019 by Kyongbo Pharm All Rights Reserved
Affiliates
- Holdings
- - Chong Kun Dang Holdings
- Healthcare
- - Chong Kun Dang
- - Chong Kun Dang Bio
- - Kyongbo Pharm
- - Chong Kun Dang Healthcare
- Real estate leasing service
- - Chong Kun Dang Industry
- Construction/Environment
- - Bell E&C
- Services/Transportation
- - Bell SM
- Marketing Solutions
- - Bell Communications
- IT
- - Bell I&S